Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Immunology of Multiple Sclerosis.
Differential transcriptional response profiles in human myeloid cell populations.
Genzyme Announces Successful Phase III Results for Alemtuzumab (LEMTRADA TM*) in Multiple Sclerosis
The role of stem cell therapy in multiple sclerosis: An overview of the current status of the clinical studies.
Multiple Sclerosis: Modulation of Toll-Like Receptor (TLR) Expression by Interferon-β Includes Upregulation of TLR7 in Plasmacytoid Dendritic Cells.
Switch to natalizumab vs fingolimod in active relapsing-remitting multiple sclerosis.
Morphogenesis of the demyelinating lesions in Baló's concentric sclerosis.
Beta-Interferon, Glatiramer Acetate Cost-Effective in MS
Neurorehabilitation Topics in Patients with Multiple Sclerosis: From Outcome Measurements to Rehabilitation Interventions.
Disease-modifying drugs for multiple sclerosis in pregnancy: A systematic review.
Parenteral Treatment of Multiple Sclerosis: The Advent of Monoclonal Antibodies.
Preclinical studies of sex differences: a clinical perspective.
Developing a Valuation Function for the Preference-Based Multiple Sclerosis Index: Comparison of Standard Gamble and Rating Scale.
Central nervous system neuroinflammatory disorders in Asian/Pacific regions.
New Data Show Strong, Sustained Effects of TECFIDERA® (Dimethyl Fumarate) in Newly-Diagnosed and Early Disease Course Multiple Sclerosis Patients
Teriflunomide
Galectin-1 is essential for the induction of MOG35-55 -based intravenous tolerance in experimental autoimmune encephalomyelitis.
Efficacy and Safety of Fingolimod in Hispanic Patients with Multiple Sclerosis: Pooled Clinical Trial Analyses.
Trimesta (Oral Estriol)
Atypical facial pain in multiple sclerosis caused by spinal cord seizures: a case report and review of the literature.
Standing up in multiple sclerosis (SUMS): protocol for a multi-centre randomised controlled trial evaluating the clinical and cost effectiveness of a home-based self-management standing frame programme in people with progressive multiple sclerosis.
Effects of dimethyl fumarate on lymphocyte subsets.
[Prevalence of multiple sclerosis in the Region of Murcia].
Genetic variation in the IL7RA/IL7 pathway increases multiple sclerosis susceptibility.
A Cross-Sectional Study of the Impact of Spasticity on Daily Activities in Multiple Sclerosis.

Pages